Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.284,87
0,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Proteostasis Therapeutics Inc (PTI) Proteostasis Therapeutics Inc (PTI) Notizie

PTI

Proteostasis Therapeutics (PTI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PTI
DataOraFonteTitoloSimboloCompagnia
29/06/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTIProteostasis Therapeutics Inc
16/06/202322:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTIProteostasis Therapeutics Inc
13/06/202316:32Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTIProteostasis Therapeutics Inc
12/06/202323:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PTIProteostasis Therapeutics Inc
01/06/202322:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PTIProteostasis Therapeutics Inc
11/05/202323:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202323:17Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202323:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTIProteostasis Therapeutics Inc
28/04/202323:12Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PTIProteostasis Therapeutics Inc
21/04/202323:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PTIProteostasis Therapeutics Inc
31/03/202322:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTIProteostasis Therapeutics Inc
14/02/202322:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTIProteostasis Therapeutics Inc
14/02/202322:16Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PTIProteostasis Therapeutics Inc
10/02/202322:55Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTIProteostasis Therapeutics Inc
10/02/202315:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTIProteostasis Therapeutics Inc
23/12/202212:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTIProteostasis Therapeutics Inc
16/12/202220:58Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PTIProteostasis Therapeutics Inc
16/12/202216:38Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:PTIProteostasis Therapeutics Inc
06/12/202222:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PTIProteostasis Therapeutics Inc
04/11/202221:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:PTIProteostasis Therapeutics Inc
20/12/202122:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PTIProteostasis Therapeutics Inc
17/08/202123:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTIProteostasis Therapeutics Inc
06/01/202123:29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PTIProteostasis Therapeutics Inc
22/12/202016:47PR Newswire (US)Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Revers...NASDAQ:PTIProteostasis Therapeutics Inc
15/12/202013:00GlobeNewswire Inc.Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with ProteostasisNASDAQ:PTIProteostasis Therapeutics Inc
16/11/202022:15PR Newswire (US)Proteostasis Therapeutics Reports Third Quarter 2020 Financial ResultsNASDAQ:PTIProteostasis Therapeutics Inc
23/09/202022:51Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PTIProteostasis Therapeutics Inc
25/08/202021:41Business WireALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Proteostasis Therapeutics, Inc.NASDAQ:PTIProteostasis Therapeutics Inc
24/08/202020:14Dow Jones NewsBiotech Startup Yumanity Sets Reverse Merger With ProteostasisNASDAQ:PTIProteostasis Therapeutics Inc
24/08/202013:00PR Newswire (US)Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger AgreementNASDAQ:PTIProteostasis Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PTI

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network